Covance Insights

Covance Introduces

We are proud to welcome several distinguished additions to our management team:

Kathryn Glase

Senior Health Economics Associate
Covance Market Access Services

Kathryn Glase specializes in systematic literature reviews and the assessment of devices. She has had wide ranging experience with medical devices, including the preparation of MSAC and Prostheses List Applications for a variety of products. In addition, Ms. Glase provides services related to the reimbursement of pharmaceuticals in Australia and New Zealand. She has a special interest in literature and information searching.

Ms. Glase joined the industry in 1997, initially as a health

researcher for INTSTAT Australia Pty Ltd, a statistical consultancy, which became part of Covance in 1999. Her work at INSTAT focused primarily on transport safety and issues relating to the need for doctors in rural and remote areas of Australia.

Ms. Glase received a Masters in Community Health from the University of Sydney and a B.S. in Nutrition and Psychology from the University of Wollongong.

Alan Goldberg, R.Ph.

Director, Drug Safety Services
Covance Periapproval Services

Alan Goldberg manages drug safety project planning, as well as set up and processing of adverse event reports; assists in the generation and review of Time and Cost Estimates for Drug Safety Service business; presents drug safety capabilities at business development presentations to clients; attends client meetings and liaise with clients; reviews cumulative drug safety data for submission to Drug Safety Monitoring Boards, regulatory authorities or clients; and manages the set up of, and provision of data to, Safety Committees and DSMBs . Mr. Goldberg was the

drug safety manager on the iPLEDGE program, managing the iPLEDGE Pregnancy Registry.

Before joining Covance in 2006, Mr. Goldberg worked at Wyeth Pharmaceuticals in Collegeville, PA as a drug safety surveillance scientist processing adverse events for oncology clinical trials, with subsequent responsibility as an Associate Director of Project Management for the drug safety department. Prior to Wyeth, Mr. Goldberg was a lead pharmacist responsible for the start up of an ambulatory care pharmacy for the University of Pennsylvania Health System. Mr. Goldberg has over 20 years experience in hospital, retail and mail order pharmacy and is licensed to practice pharmacy in the states of Pennsylvania and Florida.

Mr. Goldberg received a B.S. in Pharmacy, cum laude, from Temple University School of Pharmacy in Philadelphia, PA. At Temple University, he was a member of the Rho Chi Honor Society. Mr. Goldberg is a member of the Pennsylvania Society of Health-System Pharmacists, with previous board responsibility as Secretary and President of the local chapter. He is also an active member of the Drug Information Association (DIA), with past memberships to the American Society of Health-System Pharmacists and the American Pharmaceutical Association.

Meridith Johnson

Senior Associate
Covance Market Access Services

Meridith K. Johnson specializes in international health policy and health systems. She has assisted clients through policy analysis and coverage, coding, and reimbursement issues in the U.S. and Europe. Ms. Johnson has assessed pharmaceuticals and devices in various settings of care and in a number of different disease areas including cardiology, dermatology, diabetes, neurology, and oncology.

Prior to joining Covance, Ms. Johnson served as an information

assistant for John Snow International UK (JSIUK), which served as the U.K. Department for International Development's Resource Center on Sexual and Reproductive Health. She also served as a research assistant for The New Health Network, a British non-profit organization working for the modernization of National Health Service (NHS).

Ms. Johnson received an M.Sc. in Social Policy and Planning from the London School of Economics and Political Science and a B.A., cum laude, in Anthropology from DePauw University.

Steven Kahn, Ph.D.

Vice President, Clinical Operations
Covance Periapproval Services

Steven Kahn specializes in the design and implementation of projects in the periapproval phase of drug development. These include large simplified trials, placebo-controlled studies, and Risk Minimization Action Plans (RiskMAPs) and their implementation.

Prior to joining Covance, Dr. Kahn taught Health Care Ethics and Clinical Research Ethics. He also has worked as a nurse and in biochemistry labs.

Dr. Kahn received a Ph.D., a B.S. in Nursing from the State University of New York @ Buffalo, and a B.A. in Chemistry from Northeastern University. He is a member of the Drug Information Association (DIA).

Erin Koch

Project Director
Covance Periapproval Services

Erin Koch is responsible for overseeing project managers to ensure overall study goals are met. She has extensive experience in the monitoring and management of Phase II, IIIb, IV and post-marketing surveillance clinical trials over numerous therapeutic areas. Ms. Koch has worked on many programs with investigator and subject recruitment challenges and has instituted strategic solutions that proved to be successful. She has been recognized by several clients for her proactive management approach, open communication style and attention

to detail.

Since joining Covance in 1997, Ms. Koch has worked with Covance Periapproval Services. She has been recognized for her exceptional performance by being selected for the LEADR II (Leadership Education and Development Rotation) management training program and receiving the "Covance Way Award" in 2005.

Ms. Koch received a B.S. in Nursing from Villanova University and is a licensed R.N. in the State of Pennsylvania.

Denise McFadden

Project Director, Risk Management
Covance Periapproval Services

Denise M. McFadden has a strong background in international project management, clinical trial management, operations, and IT implementation. As Manager of Operations at Covance's Interactive Voice Response System (IVRS) division, she ran IVRS studies and oversaw training for the entire division. She supervised the European field office for international clinical studies and managed all studies for one of Covance's largest clients, Novartis. Later, as the head of training for the division, she organized new employee education, updated curriculum for

new Standard Operating Procedures, and ensured proper documentation. Currently, she works in Covance's Periapproval Risk Management Division on the iPLEDGE program, an FDA mandated RiskMAP program for isotretinoin.

Prior to joining Covance, Ms. McFadden was the Director of Operations for TRILLION Corporation, a technology company that provides network equipment to Tier 1 telephone companies like AT&T.

She also worked for Merck & Company as Clinical Project Manager, handling all aspects of their clinical trials including recruiting for studies, creating Case Report Forms (CRFs), and implementing trial protocols.

Ms. McFadden received a B.A. in Interdisciplinary Science (concentration in Biology) from Arcadia University.

Lori Thorell

Project Director, Clinical Operations
Covance Periapproval Services

Lori Thorell is responsible for overseeing Project Managers to ensure that overall study goals are met. She is also responsible for ensuring that all studies conducted for any particular sponsor are managed consistently through shared best practices and knowledge of that sponsor's processes. Ms. Thorell also works with Business Development and Sales on new business opportunities and contributes to various company initiatives.

Prior to joining Covance in 1998, Ms. Thorell worked at both

Johns Hopkins University and University of Pennsylvania performing research. She originally joined Covance as a Clinical Services Associate (CSA). During her time at Covance, Ms. Thorell has worked on several Phase IIIb and IV studies in a variety of therapeutic areas including pain management, asthma, dialysis, renal disease, diabetes, and infectious disease.

In 2003 and 2005, Ms. Thorell won the Covance Way Award, given to the top 1% of the company in recognition of commitment towards the vision of Covance: Science, Service, and Shaping Solutions.

Ms. Thorell received a B.S. in Biology from Ursinus College and has taken graduate courses towards an M.B.A. in pharmaceutical marketing. She is a member of the Healthcare Businesswoman's Association and the Drug Information Association (DIA).

www.covance.com/commercialization

info@covance.com

Covance is an independent, publicly held company with headquarters in Princeton, New Jersey, USA. Covance is the marketing name for Covance Inc. and its subsidiaries around the world. The use of "Covance" in this newsletter refers to one of these subsidiaries. Copyright Covance Market Access Services Inc., 2007. All rights reserved.

2nd Quarter 2007

Covance Introduces